Chugai Pharmaceutical Hits Day High with Strong 3.49% Intraday Surge

Chugai Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 3.49% as of March 24, 2026. The stock reached an intraday high of JPY 8,224.00, reflecting a notable performance against the backdrop of the Japan Nikkei 225, which increased by 1.43% during the same period. Despite a challenging week, where Chugai's stock fell by 11.74%, its year-to-date performance remains relatively stable, down just 0.23%. Over the past year, the stock has delivered an 18.83% return, although it has underperformed compared to the Nikkei 225's 38.94% gain. Chugai's financial metrics indicate strong long-term fundamentals, with a return on equity (ROE) of 22.39% and a price-to-book ratio of 7.33. The company has demonstrated healthy growth, with net sales increasing at an annual rate of 11.43% and operating profit rising by 19.46%. Additionally, Chugai has maintained a low debt level, ensuring it can comfortably meet its financial obligations. Overall, the stock's performance today highlights its resilience in the pharmaceuticals and biotechnology sector.